Abstract
The objective of this paper is to assess if real-time intermittent Continuous Glucose Monitoring (CGM) helps to improve the control of glycemic and outcome of pregnancy in women with diabetes. A total of 123 women with type 1 diabetes and 31 women with type 2 diabetes respectively were used at random in the Continuous Glucose Monitoring for a total of 6 days at different stages of pregnancy. Results revealed that intermittently using real-time Continuous Glucose Monitoring in pregnancy plus plasma glucose which is self-monitored does not really help to improve the control of glycemic or outcome of pregnant women with diabetes.
Highlights
Of the complications that a pregnant woman may face, one of the most serious ones is gestational diabetes
Results revealed that intermittently using real-time Continuous Glucose Monitoring in pregnancy plus plasma glucose which is self-monitored does not really help to improve the control of glycemic or outcome of pregnant women with diabetes
Participants who were in the intervention arm were given the intermittent Continuous Glucose Monitoring for about 6 days at their very first visit for pregnancy which was at 2 months
Summary
Of the complications that a pregnant woman may face, one of the most serious ones is gestational diabetes. While some women are informed about the disease, substantial majorities lack the relevant information and this compromises their lives and the life of the unborn baby. Diabetes in expectant women is major as a result of outcomes that are adverse of perinatal which are distributed largely to hyperglycemia maternity as well as morbidity perinatal, preterm delivery and large gestational infants. The large gestational infants are a very high risk of birth trauma to mothers with diabetes as well as transient tachypnea and hypoglycemia neonatal. The major setback in striving towards glycemic maternal control is the severe hypoglycemia risk. Glucose Monitoring (CGM) is used to measure glucose in the interstitial in the fashion that is ongoing and helps offer a chance of hypoglycemic
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have